SCHEMBL4263233

SCHEMBL4263233

O=C(O)c1noc2c1CN(C(=O)COc1ccc(Cl)cc1)CC2

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.50
MAPT P10636 3/20 0.50
HPGD P15428 2/20 0.50
RAB9A P51151 1/20 0.50
ENPP2 Q13822 3/20 0.47
MEN1 O00255 1/20 0.47
GPR183 P32249 1/20 0.47
KMT2A Q03164 1/20 0.47
ALDH1A1 P00352 3/20 0.47
LMNA P02545 2/20 0.47
KDM4E B2RXH2 2/20 0.47
HTT P42858 1/20 0.47
PRLHR P49683 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
PKM P14618 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
ATF4 P18848 1/20 0.43
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4267581 0.90 KMT2A (0.52) POLBMAPTHPGDRAB9AMEN1
SCHEMBL4267230 0.88 FKBP1A (0.54) POLBMAPTENPP2MEN1KMT2A
SCHEMBL2580830 0.84 ATF4 (0.51) POLBMAPTHPGDRAB9AMEN1
SCHEMBL4271034 0.79 SMN1; SMN2 (0.60) POLBMAPTHPGDRAB9AKMT2A
SCHEMBL4261756 0.77 GRM5 (0.48) RAB9AKMT2ALMNA
SCHEMBL5533937 0.77 ATF4 (0.49) POLBMAPTHPGDRAB9AALDH1A1
SCHEMBL4272825 0.77 SMN1; SMN2 (0.53) MAPTHPGDRAB9AMEN1KMT2A
SCHEMBL4274929 0.76 GAA (0.55) POLBMAPTHPGDRAB9AMEN1
SCHEMBL5529317 0.75 MEN1 (0.50) POLBMAPTHPGDRAB9AMEN1
SCHEMBL5531763 0.74 FKBP1A (0.53) POLBMAPTENPP2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments GRUENENTHAL GMBH (DE) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments P2RX5, P2RX4, P2RX7 POLB 4291/4885MAPT 3693/4885HPGD 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.